Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial
| Autor: | Kuriyama, Kenji, Murakami, Kyoko, Masuda, Taisei, Sugiura, Kenkichi, Sakui, Sho, Schuring, Ron P., Mori, Mitsuhiro |
|---|---|
| Zdroj: | In Vaccine 7 June 2023 41(25):3763-3771 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect